GINGILONE

This brand name is authorized in Brazil

Active ingredients

The drug GINGILONE contains a combination of these active pharmaceutical ingredients (APIs):

1 Troxerutin
UNII 7Y4N11PXO8 - TROXERUTIN

The pharmacodynamic effects of oxerutins have been demonstrated in different in vitro and in vivo studies. At the cellular level the capability of oxerutins to protect the vascular wall from the oxidative attack of activated blood cells and its affinity to the endothelium of capillaries and venoles could be shown.

Read about Troxerutin
2 Neomycin
UNII 057Y626693 - NEOMYCIN SULFATE

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

Read about Neomycin
3 Vitamin C
UNII PQ6CK8PD0R - ASCORBIC ACID

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.

Read about Vitamin C
4 Hydrocortisone
UNII 3X7931PO74 - HYDROCORTISONE ACETATE

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.

Read about Hydrocortisone
5 Benzocaine
UNII U3RSY48JW5 - BENZOCAINE

Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited.

Read about Benzocaine

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 540915100016017

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.